3650--Albany Radiopharmaceuticals - Nuclear Medicine
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued.
This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2020-07
This solicitation is for Full and Open Competition
The associated North American Industrial Classification System (NAICS) code for this procurement is 325412, with a small business size standard of 1000 employees.
The FSC/PSC is 3650.
The Albany VA Medical Center, 113 Holland Avenue, Albany, NY 12208 has a requirement for a United States Nuclear Regulatory Commission (US NRC) and Food and Drug Administration (FDA) Licensed Contractor to provide radiopharmaceuticals for the Nuclear Medicine Department for patient care.
All interested companies shall provide quotations for the following:
Supplies/Services
Statement of Work
Radiopharmaceuticals
1.0 SCOPE
The Department of Veterans Affairs Stratton VA Medical Center (VAMC) located at 113 Holland Avenue, Albany, NY 12208 has a requirement for a United States Nuclear Regulatory Commission (US NRC) and Food and Drug Administration (FDA) Licensed Contractor to provide radiopharmaceuticals for the Nuclear Medicine Department for patient care. The Albany VAMC intends to award a base year plus two option years, firm fixed price, Requirements Contract to a licensed Radiopharmacy authorized to manufacture and distribute Radiopharmaceutical Supplies and Services in New York State with a period of performance of October 1, 2020 through September 30, 2023. The Contractor agrees in accordance with the terms and conditions stated herein, to furnish Radiopharmaceuticals in accordance with Federal, State, and Local Regulations. The Contractor shall be able to provide all of the items listed in the Schedule of Radiopharmaceuticals with deliveries when required. Multiple awards will not be made.
1.1 BACKGROUND
The Stratton VAMC is responsible for providing high quality and timely commodities and services for our Veterans. One area to serve our Veterans is to ensure that the best possible medical supplies are both timely and in accordance with proper regulations with Contractors that are licensed and monitored according to Federal, State, and Local Regulations. Under the Atomic Energy Act, the US NRC is responsible for regulating uses of radioactive material, including radio pharmaceuticals. The US NRC requires all nuclear medicine facilities to be licensed. The license assures that the facility has a radiation protection program to protect both the patients and the staff. In addition, the staff must meet certain standards of training and experience before they are allowed to administer radioactive material to patients. Each state has one or more radiation programs that ensure the safe use of radioactive materials. The US NRC has transferred regulatory authority over the use of this material to 35 NRC Agreement States. In these states, the regulatory authority inspects the facility to ensure the staff is trained properly and the equipment is operating safely. FDA s Center for Drug Evaluation and Research regulates the radio pharmaceuticals, ensuring effectiveness and patient safety. The mission of The National Institute of Standards and Technology (NIST) is to develop and promote measurement, standards, and technology to enhance productivity, facilitate trade, and improve the quality of life.
2.0 STATEMENT OF WORK
1. The Contractor agrees to provide all listed radiopharmaceuticals as identified in the Schedule of Radiopharmaceuticals to the Stratton VAMC on a daily or as needed basis in accordance with this Statement of Work. Because of the critical need for these supplies in a timely manner, only Contractors that can deliver within two hours to the Stratton VAMC need to respond to this solicitation. Time is of the essence for all deliveries. These delivery timeframes are absolutely critical to ensure proper patient care and safety. The two-hour timeframe shall include the following: order processing, compounding order, travel, locating parking at the Medical Center, and delivery of radiopharmaceuticals to Radiology. The Contractor shall be licensed by the State of New York or another agreement state approved by the Nuclear Regulatory Commission and shall be regularly established in the business of providing radionuclides in accordance with New York State regulations. The Contractor shall provide evidence of delivery in less than 2 hours with their proposal. The Contractor shall identify the location of the point of shipment to the address listed in the first paragraph of this solicitation. Verification will be completed via www.mapquest.com.
2. Deliveries will incorporate sufficient lead or other high-density metal shielding to comply with all applicable Federal, State, and Local standards relating to shipment of radioactive materials. Shipping containers must comply with all Federal and State regulations. This will include the FDA, DOT, DOE, USNRC, and ICC regulations and standards. Documentation of US DOT package integrity testing shall also be provided with each delivery.
3. Items must be adequately packaged to prevent damage during handling and storage. All packaging and labeling must meet all Federal, State, and Local regulations. All packaging of radioactive material must be clearly labeled RADIOACTIVE on the outside of the carton in which it is shipped.
4. The Contractor shall label all products delivered to the Stratton VAMC with the radiopharmaceutical, activity, time of preparation, and expiration time and date.
5. The Contractor shall hold a current unrevoked NRC or an agreement state radioactive materials license, which in addition to other license conditions, would allow for the receipt and disposal of radioactive material, as well as an FDA license to produce and distribute radiopharmaceuticals for human administration. The Contractor shall provide a copy of their radioactive material license with their proposal. The Contractor shall immediately notify the Contracting Officer (CO) and the Contracting Officer Representative (COR), upon any action by the NRC or an agreement state or the FDA to suspend or modify their radioactive materials license. The Contractor shall provide radiopharmaceuticals which have been prepared according to manufacturer s package inserts and applicable FDA requirements. The Contractor shall perform all quality control procedures as required by Federal and State Regulatory Agencies.
6. The Contractor will provide with their proposal all of the following information for paragraphs a through d:
a. The Contractor s regular work hours.
b. The Contractor s telephone number for call-in orders during regular work hours.
c. The Contractor s telephone number and instructions for placing Emergency orders after the Contractor s regular work hours to include weekends.
d. The Contractor s telephone number for expert advice concerning awarded products.
e. The Contractor will furnish a statement that any radiopharmaceuticals delivered as ready-to-use (individual doses in syringes or vials for single or multiple uses) will have quality control performed by the Contractor, so that the delivered product will comply with the requirements of the Joint Commission (JC) and with the United States Pharmacopeia.
f. Should any changes occur in the above information during the contract period of performance the Contractor will immediately provide all applicable updates in writing to the CO and COR.
7. Current package inserts of all radiopharmaceuticals supplied under the awarded contract will be shipped to the Nuclear Medicine Service at the inception of the contract. If any new or updated additions to the package inserts are made available, these will be sent to the COR at the Stratton VAMC Nuclear Medicine Department.
8. The Contractor shall make quality control records available upon written request from the CO or COR.
9. The Contractor shall test all products for Quality Control periodically. This testing shall be performed at no cost to the Government. The Contractor shall provide a detailed description of the test results when requested.
10. The calibration time for each requested radiopharmaceutical shall be provided in the Schedule of Radiopharmaceuticals as part of the Contractor s proposal pricing.
11. If an ordered dosage of radioactive material is given to the Contractor such that it is to fall within a specified range, then the quantity of radioactivity must be within the dose range provided. If dose is not given in a range, then the quantity of radioactivity for supplied radiopharmaceuticals will not deviate more than ±20%.
12. Technetium product radiopharmaceuticals not used will be returned for credit the next workday (including the bulk doses), using the DOT regulations. Credit will be reflected in the current month s invoice.
13. The Contractor shall replace any items delivered damaged or in error at no cost to the Government. The COR shall define the replacement date and time. Replacements may be required immediately or within a specified time in accordance with patient needs.
14. The expiration date and time shall be indicated and affixed to each product as noted below; in general:
a. Ready-to-use doses: not shorter than six (6) hours.
b. Tc-99m pertechnetate: Not shorter than twelve (12) hours.
c. Kits intended for reconstitution by user: Not shorter than three (3) months from date of delivery.
d. Unused kits having expiration time not less than two (2) weeks will be exchanged by the Contractor at no additional charge for a comparable kit having the three (3) months life span.
15. In the event that a quality control or material defect is suspected or detected by the COR, the Contractor will be requested to provide any consultation necessary to alleviate any said suspicion or defect by the following:
a. Provide technical expertise in calibration.
b. Provide professional examination of product. Submit results and recommendations to the COR.
c. Make expedient replacement of any product suspected of being deficient.
16. Approximately five (5) times per year, the below procedures are to be followed for labeling of patient's white blood cells (WBC) with Indium-111 Oxine or Tc-Ceretec, for re-injecting to the same patient:
a. Telephone requests to the Contractor to arrange for the procedure will take place no later than 3:30 PM for the next workday procedure.
b. The Contractor shall be at the Nuclear Medicine Department no later than 8:30 AM to pick up the patient's blood specimen for labeling.
c. The return by the Contractor, of the patient's Indium or Tc-Ceretec labeled white blood cells will take place no more than 5 (five) hours from the time of specimen pick up time.
d. Pertinent documentation confirming that the identification of the labeled blood specimen matches with the blood specimen of the patient's blood specimen submitted for labeling procedure.
17. The Contractor shall pick up radiopharmaceuticals (used and unused) for proper disposal at no cost to the Government.
18. The Contractor shall produce radiopharmaceuticals as described in the Schedule of Radiopharmaceuticals.
3.0 Deliverables and Acceptance Criteria
1. The Contractor shall provide services and staff, and otherwise do all things necessary for or incidental to the Statement of Work, as set forth below:
a. Provide up to two deliveries per day during regular operating hours to the Stratton Nuclear Medicine Service at no additional charge. The delivery charge for emergency orders to be included on the Schedule of Radiopharmaceuticals. The Delivery charge for STAT orders is to be included on the Schedule of Radiopharmaceuticals. STAT deliveries will average, three (3) times a week.
b. Deliver directly to the Stratton Nuclear Medicine Service daily quantity of radiopharmaceuticals by 7:00 AM, as requested from the previous workday by 4:00 PM, unless otherwise noted as an emergency, requiring a two-hour turnaround time.
c. Second daily delivery, if necessary, must be delivered no later than 11:00 AM.
d. Orders can be placed orally by telephone by Ordering Officers provided by the COR.
e. Deliver directly to the Nuclear Medicine Service at the Stratton VAMC, the quantity of radiopharmaceutical requested on an emergency basis to arrive in less than two (2) hours after notification.
f. Radioactive dose boxes that are delivered outside of working hours will be delivered to Nuclear Medicine. The Contractor shall not leave a radioactive materials package at the Stratton VAMC unless they have verbally communicated with a Nuclear Medicine staff member.
g. Other delivery times may be outlined by the Stratton VA Medical Center in this Statement of Work.
2. On Federal Holidays, no normal deliveries will be expected. If Monday is a Federal Holiday, no deliveries will be expected. Holidays are listed under 4.0 VA Operating Hours.
3. Emergency deliveries may be requested at any time outside normal delivery times, including weekends, holidays, and nights.
4. Shipments requested as an Emergency will be delivered as follows:
a. Requests placed after regular work hours (weekends, holidays, and nights) will be delivered within two (2) hours, or as specified.
b. Emergency, weekend, and holiday deliveries are to be delivered to location(s) specified by the Stratton VA Nuclear Medical Department, unless otherwise specified when called for.
c. Emergency deliveries will be required within two (2) hours after the order is placed.
d. All shipments will be labeled as RADIOACTIVE MATERIAL in compliance with all pertinent regulations.
e. All Radiopharmaceuticals, Radioassay Kits, and Analytic Kits are to be furnished by the Contractor in strict accordance with the terms and conditions of the contract and all applicable Federal, State, and Local Laws.
f. Delivery dates, times, frequency of deliveries, specific dosages, and all other specific requirements by the Stratton VAMC in this Statement of Work will be strictly adhered to.
5. All shipments must have a Packing Slip enclosed, giving information about the product and its identification, plus (for billing purposes) the Stratton VAMC Purchase Order Number issued for the current fiscal year, and the Contractor s invoice number. Providing incorrect Purchase Order numbers on invoices will cause a substantial delay in payments to the Contractor.
4.0 VA OPERATING HOURS
The delivery of products provided by the respective awarded contract shall be furnished by the Contractor in accordance with section 3.0 Deliverables and Acceptance Criteria. The Contractor shall not be required, except in case of an emergency, to furnish such products on a national holiday or during non-working hours as described below with the exception of normal next day delivery.
The following terms have the following meanings:
Normal Operating hours of Nuclear Medicine: Monday through Friday, 7:00 AM to 4:00 PM Eastern Standard Time
Normal deliveries shall be accomplished at 7:00 AM and 11:00 AM. The Contractor to include up to two (2) deliveries per normal working day during normal working hours as needed at no additional charge.
National Holidays: The ten (10) holidays observed by the Federal Government are as follows:
New Year's Day, Martin Luther King's Birthday, President s Day, Memorial Day, Independence Day, Labor Day, Columbus Day, Veteran's Day, Thanksgiving, and Christmas, and any other day specifically declared by the President of the United States to be a national holiday.
5.0 CONTRACT AWARD
Upon Contract Award (within five (5) business days) the awarded Contractor shall provide:
1. A copy of their Laboratory s current quality control manual to the COR.
2. A dedicated inside sales representative to aide in facilitation in the smooth coordination between the Stratton VA Medical Center and the Contractor s Laboratory Pharmacy.
3. Material safety data sheets and updates on all delivered products as per contract award to include any additions throughout the period of performance of the awarded contract.
4. Patient orientation education video presentations and other appropriate material at no additonal cost to the Government.
5. The Contractor shall provide signs and posters alerting patients, employees and the public, of safety precautions in the handling of radioactive materials.
6.0 QUALITY REQUIREMENTS
The Contractor shall guarantee the quality of their radiopharmaceuticals. Quality Control (QC) shall include pH testing, percent tag, alumina, and 99Mo breakthrough as appropriate. Quality Control shall be performed on each agent dispensed. Complete documentation of QC results will be provided upon request. All radiopharmaceuticals shall be calibrated and labeled with concentration, time, total volume, and total activity. Consultation service regarding radiopharmaceutical applications, problems, controls, shall be provided upon request at no charge. On an annual basis, the Contractor shall provide documentation demonstrating compliance with applicable agreement state or NRC license requirements to the Radiation Safety Officer or COR.
7.0 PERSONNEL POLICY
The Contractor is responsible for all costs, including personnel costs, associated with the awarded contract, unless otherwise specified.
Qualifications - Personnel assigned by the Contractor to prepare and provide the products covered within this Statement of Work shall be Nuclear Pharmacists or a Licensed Technologist working under the supervision of a Nuclear Pharmacist licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia.
8.0 SPECIAL CONTRACT REQUIREMENTS: HHS/OIG
To ensure that the individuals providing services under the respective awarded contract have not engaged in fraud or abuse regarding Sections 1128 and 1128A of the Social Security Act regarding Federal Health Care Programs, the Contractor is required to check the Health and Human Services - Office of Inspector General (HHS/OIG), List of Excluded Individuals/Entities on the OIG Website for each person providing services under the respective awarded contract. The listed parties and entities may not receive Federal Health Care program payments due to fraud or abuse of the Medicare and Medicaid programs. During the period of performance of the respective awarded contract the Contractor is prohibited from using any individual or business listed on the List of Excluded Individuals/Entities. Any healthcare provider or entity that employ or enter into contracts with excluded individuals or entities may have a Civil Monetary Penalty imposed against them. By signing their proposal, the Contractor certifies that all persons or entities listed in the Contractor s proposal have been compared against the OIG list and are not listed as of the date their proposal was signed.
9.0 CONTRACTOR STAFF ROLES AND RESPONSIBILITIES
The Contractor must be in compliance with all Nuclear Regulatory Commission, United States Pharmacopeia, United States Food and Drug Administration, State, Local and Joint Commission guidelines, as well as United States Pharmacopeia 797 guidelines.
10.0 CONTRACTOR PERFORMANCE ASSESSMENTS (CPARS)
Assessments: The Government will complete assessments of the Contractor s performance. The Contractor shall have an opportunity to respond to said assessments.
Record: The Government will keep completed assessments that will serve as past performance data. Past performance data will be available to assist agencies in the selection of radio-pharmacy Contractors for future contracts.
11.0 DESIGNATION OF CONTRACT OFFICER REPRESENTATIVE (COR)
The COR will be designated in writing. The COR will be furnishing technical guidance and advice regarding the work being performed under the respective awarded contract. The foregoing is not to be construed as authorization to interpret or furnish advice and information to the Contractor relative to the financial or legal aspects of the respective awarded contract. Enforcement of these segments is vested in and is the responsibility of the Contracting Officer.
12.0 CONTRACTOR RECALL AND SAFETY PLAN AND PROCESS NOTIFICATION TO FACILITY
The Contractor shall take immediate action to notify the COR whenever a product, piece of equipment or item is recalled or considered dangerous, hazardous or unsafe in order to remove such products, equipment or items from use. This notification process also applies to safety alerts. The Contractor recall and safety notification plan and process are necessary so that proper notification to individuals who have received or individuals who may utilize such products, equipment or items can be made in an expedient and efficient manner as possible. The Contractor shall provide to the COR their plan for this safety notification process and maintain a record system in order to document any safety incident issues by their date, time, and description of the recall or safety alert issue provided to the COR.
13.0 HIPAA COMPLIANCE
The Contractor must adhere to the provisions of Public Law 104-191, Health Insurance Portability and Accountability Act (HIPAA) of 1996 and the National Standards to Protect the Privacy and Security of Protected Health Information (PHI). As required by HIPAA, the Department of Health and Human Services (HHS) has promulgated rules governing the security and use and disclosure of protected health information by covered entities, including the Department of Veterans Affairs (VA).
14.0 AVAILABILITY OF FUNDS DURING A CONTINUING RESOLUTION
At the beginning of each new fiscal year (1 October) the Federal Government or parts thereof may be operating under a Continuing Resolution (CR) and only be funded for a limited period of time rather than for the entire fiscal year. If at any time funds for this contract are provided under a CR, funds will only be available for performance under the respective awarded contract up to and including the expiration date of the CR, and any extension thereof. The Government's obligation for performance of the respective awarded contract beyond that date is contingent upon the availability of appropriated funds from which payment for contract purposes can be made. No legal liability on the part of the Government for any payment may arise for performance under the respective awarded contract beyond the expiration date of the CR, and any extension thereof, until funds are made available to the Contracting Officer for performance and until the Contractor receives notice of availability.
15.0 REQUIRED REGISTRATION WITH CONTRACTOR PERFORMANCE ASSESSMENT SYSTEM (CPARS)
As prescribed in Federal Acquisition Regulation (FAR) Part 42.15, the Department of Veterans Affairs (VA) evaluates Contractor past performance on all contracts that exceed the thresholds outlined in FAR Part 42.15, and shares those evaluations with other Federal Government Contracting Specialists and procurement officials through the Past Performance Information Retrieval System (PPIRS). The FAR requires that the Contractor be provided an opportunity to comment on past performance evaluations prior to the posting of each report. To fulfill this requirement VA uses an online database, the Contractor Performance Assessment Reporting System (CPARS). The CPARS database information is uploaded to the Past Performance Information Retrieval System (PPIRS) database, which is available to all Federal agencies. Each Contractor whose contract award is estimated to exceed the thresholds outlined in FAR Part 42.15 is required to provide to the Contracting Officer contact information for the Contractor s representative with their response to the solicitation. The Contractor is responsible to notify the Contracting Officer of any change to the Contractor s representative during the contract period of performance. The Contractor s representative contact information consists of their name, telephone number, and email address.
The Government will register the respective awarded contract within thirty (30) days after contract award. For contracts exceeding one (1) year, the Contracting Officer will evaluate the Contractor s performance annually. Intermediate reports will be filed each year until the last year of the contract, when the final report will be completed. Each report shall be forwarded in CPARS to the Contractor s designated representative for comment. The Contractor s representative will have thirty (30) days to submit any comments and return the report to the VA Contracting Officer. Failure by the contractor to respond within those thirty (30) days will result in the Government s evaluation being placed on file in PPIRS without contractor s comments.
16.0 PROHIBITION (WORKING OUTSIDE OF US)
The entire performance of the respective awarded contract shall be within the borders of the United States of America. The Contractor shall not access any Department of Veterans Affairs data information (for example, by remote computer access) from locations that are outside the above-stated borders. Furthermore, the Contractor shall not send, transfer, mail, or otherwise transmit any Department of Veterans Affairs data or information to locations outside the above-stated borders.
17.0 CONTRACT TERM
The respective awarded IDIQ contract shall be for one (1) base year and two (2) option years. The base year period of performance is from October 1, 2020 through September 30, 2021. Option year one (1) period of performance is from October 1, 2021 through September 30, 2022. Option year two (2) period of performance is from October 1, 2022 through September 30, 2023.
18.0 Schedule of Radiopharmaceuticals
Please Note: Your proposal must provide pricing on ALL items in the Schedule of Radiopharmaceuticals Required and all four columns must be filled in with your proposal.
Prices quoted are all inclusive including all associated costs including shipping, handling, packaging, storage, licenses etc. excluding emergency delivery, Pharmacist After-Hour Emergency Call-Back and Weekend White Blood Cell labeling charge.
CLIN Radiopharmaceutical Unit of Measure Qty Size Price For Each mCi or Bulk Total Price Number of Minutes Needed to Prepare Product at Radiopharmacy NDC Of Offered Product
0001 Tc99m (Bulk) Pertechnetate Bulk dose 4 250 mCi
0002 Cardiolite Unit dose 400 30mCi
0003 Cardiolite Unit dose 400 10mCi
0004 MAA Unit dose 30 6mCi
0005 DTPA Unit dose 40 75mCi
0006 MDP Unit dose 90 25mCi
0007 Sulfur Colloid (Liver/ Spleen or gastric emptying) Unit dose 20 6mCi
0008 Tc99m Pertechnetate (MUGA/Hemangioma ) Unit dose 30 25mCi
0009 Choletec Unit dose 25 6mCi
0010 PYP (MUGA/Hemangioma) Unit dose 30 1 Vial
0011 Mag-3 Unit dose 20 10mCi
0012 Certec WBC Study 10 10-30mCi
0013 Octreotide Unit dose 10 6mCi
0014 I-123 200 s Caps 40 200mCi
0015 I-131 Therapy/Whole Body 1 6 mCi) Caps 5 Up to 6mCi
0016 I-131 Therapy (per mCi) Caps 5 Up to 6mCi
0017 Thallium 201 Unit dose 1 5mCi
0018 Gallium 67 Unit dose 1 10mCi
0019 Sulfur Colloid (filtered) Unit dose 15 250uCi
0020 Thallium 201 Brain Unit dose 4 5mCi
0021 Tc99m Pertechnetate Meckel s Thyroid Imaging Unit dose 1 10mCi
0022 Cardiolite (Parathyroid) Unit dose 15 25mCi
0023 Ceretec Brain (Brain Imaging) Unit dose 3 30mCi
0024 Sulfur Colloid (gastric emptying) Unit dose 20 1mCi
0025 Tc99 Pertechnetate (hemangioma) Unit dose 10 25mCi
0026 PYP (hemangioma) Unit dose 10 1 Vial
0027 Tc99m Pertechnetate (Thyroid Imaging) Unit dose 5 10mCi
0028 Thallium 201 (stress cardiac) Unit dose 5 4mCi
0029 DATSCAN I-123 Ioflupane 1 Vial 5 3 -5mCi
0030 Quadramet Therapy Unit 1
0031 Emergency order fee to include Pharmacist preparation and delivery Delivery Approx. 3 per week. Estimate156 Annually Order
CLIN Radiopharmaceutical Unit of Measure Qty Size Price For Each mCi or Bulk Total Price Number of Minutes Needed to Prepare Product at Radiopharmacy NDC Of Offered Product
1001 Tc99m (Bulk) Pertechnetate Bulk dose 4 250mCi
1002 Cardiolite Unit dose 400 30mCi
1003 Cardiolite Unit dose 400 10mCi
1004 MAA Unit dose 30 6mCi
1005 DTPA Unit dose 40 75mCi
1006 MDP Unit dose 90 25mCi
1007 Sulfur Colloid (Liver/ Spleen or gastric emptying) Unit dose 20 6mCi
1008 Tc99m Pertechnetate (MUGA/Hemangioma) Unit dose 30 25mCi
1009 Choletec Unit dose 25 6mCi
1010 PYP (MUGA/Hemangioma) Unit dose 30 1 Vial
1011 Mag-3 Unit dose 20 10mCi
1012 Certec WBC Study 10 10-30mCi
1013 Octreotide Unit dose 10 6mCi
1014 I-123 200 s Caps 40 200mCi
1015 I-131 Therapy/Whole Body 1 6mCi) Caps 5 Up to 6mCi
1016 I-131 Therapy (per mCi) Caps 5 Up to 6mCi
1017 Thallium 201 Unit dose 1 5mCi
1018 Gallium 67 Unit dose 1 10mCi
1019 Sulfur Colloid (filtered) Unit dose 15 250uCi
1020 Thallium 201 Brain Unit dose 4 5mCi
1021 Tc99m Pertechnetate Meckel s Thyroid Imaging Unit dose 1 10mCi
1022 Cardiolite (Parathyroid) Unit dose 15 25mCi
1023 Ceretec Brain (Brain Imaging) Unit dose 3 30mCi
1024 Sulfur Colloid (gastric emptying) Unit dose 20 1mCi
1025 Tc99 Pertechnetate (hemangioma) Unit dose 10 25mCi
1026 PYP (hemangioma) Unit dose 10 1 Vial
1027 Tc99m Pertechnetate (Thyroid Imaging) Unit dose 5 10mCi
1028 Thallium 201 (stress cardiac) Unit dose 5 4mCi
1029 DATSCAN I-123 Ioflupane 1 Vial 5 3-5mCi
1030 Quadramet Therapy Unit 1
1031 Emergency order fee to include Pharmacist preparation and delivery Delivery Approx. 3 per week. Estimate156 Annually Order
Option Year Two (October 1, 2022 through September 30, 2023)
CLIN Radiopharmaceutical Unit of Measure Qty Size Price For Each mCi or Bulk Total Price Number of Minutes Needed to Prepare Product at Radiopharmacy NDC Of Offered Product
2001 Tc99m (Bulk) Pertechnetate Bulk dose 4 250mCi
2002 Cardiolite Unit dose 400 30mCi
2003 Cardiolite Unit dose 400 10mCi
2004 MAA Unit dose 30 6mCi
2005 DTPA Unit dose 40 75mCi
2006 MDP Unit dose 90 25mCi
2007 Sulfur Colloid (Liver/ Spleen or gastric emptying) Unit dose 20 6mCi
2008 Tc99m Pertechnetate (MUGA/Hemangioma) Unit dose 30 25mCi
2009 Choletec Unit dose 25 6mCi
2010 PYP (MUGA/Hemangioma) Unit dose 30 1 Vial
2011 Mag-3 Unit dose 20 10mCi
2012 Certec WBC Study 10 10-30mCi
2013 Octreotide Unit dose 10 6mCi
2014 I-123 200 s Caps 40 200mCi
2015 I-131 Therapy/Whole Body 1 6mCi) Caps 5 Up to 6mCi
2016 I-131 Therapy (per mCi) Caps 5 Up to 6mCi
2017 Thallium 201 Unit dose 1 5mCi
2018 Gallium 67 Unit dose 1 10mCi
2019 Sulfur Colloid (filtered) Unit dose 15 250uCi
2020 Thallium 201 Brain Unit dose 4 5mCi
2021 Tc99m Pertechnetate Unit dose 1 10mCi
2022 Cardiolite (Parathyroid) Unit dose 15 25mCi
2023 Ceretec Brain (Brain Imaging) Unit dose 3 30mCi
2024 Sulfur Colloid (gastric emptying) Unit dose 20 1mCi
2025 Tc99 Pertechnetate (hemangioma) Unit dose 10 25mCi
2026 PYP (hemangioma) Unit dose 10 1 Vial
2027 Tc99m Pertechnetate (Thyroid Imaging) Unit dose 5 10mCi
2028 Thallium 201 (stress cardiac) Unit dose 5 4mCi
2029 DATSCAN I-123 Ioflupane 1 Vial 5 3- 5mCi
2030 Quadramet Therapy Unit 1
2031 Emergency order fee to include Pharmacist preparation and delivery Delivery Approx. 3 per week. Estimate156 Annually Order
After hour/Emergency charges Stratton VA Medical Center
Deliveries during normal work hours (Monday - Friday) at no charge. Offeror (s) may list any additional charges below:
Deliveries during normal business hours Day: No Charge
Emergency Delivery1 Each:
Pharmacist After-Hour Emergency Call-Back2 Each:
Weekend White Blood Cell labeling charge3 Each:
Emergency Delivery: Charge for delivering unscheduled Emergency orders during normal business hours within two (2) hours of receiving the order by phone from the Stratton VA Medical Center Nuclear Medicine Department.
Pharmacist (Emergency after hours): The charge for having a Pharmacist called back to the Pharmacy after hours, prepare the ordered dose and have it delivered to the VA within two hours. (Emergency orders only).
Weekend WBC labeling charge: The charge for the pharmacy to attach a radionuclide to the patient s white blood cells on a weekend.
The contract period of performance is October 1, 2020 through September 30, 2023.
Place of Performance/Place of Delivery
Address: Albany VA Medical Center
113 Holland Ave.
Albany, New York
Postal Code: 12208
Country: UNITED STATES
The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html.
The following solicitation provisions apply to this acquisition:
1. FAR 52.212-1, Instructions to Offerors Commercial Items
2. FAR 52.212-3, Offerors Representations and Certifications Commercial Items
Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://www.sam.gov/portal in accordance with FAR 52.212-3, Offerors Representations and Certifications Commercial Items. If paragraph (j) of the provision is applicable, a written submission is required.
The following contract clauses apply to this acquisition:
FAR 52.212-4, Contract Terms and Conditions Commercial Items [Oct 2008]
FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders [June 2020]
All quotes shall be sent to the Contracting Officer: Sam DeMuzio, sam.demuzio@va.gov
Award will be based upon a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of FAR 13. Comparative evaluation is the side by side pairwise comparison of quotes based on factors resulting in a Contracting Officer decision for the quote most favorable to the Government.
The following are the decision factors:
Technical, Past Performance and Price
The award will be made to the response most advantageous to the Government.
Responses should contain your best terms, conditions.
To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows:
"The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition."
OR
"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"
Quoters shall list exception(s) and rationale for the exception(s), if any.
Submission of your response shall be received not later than August 12, 2020, 4:00 pm at sam.demuzio@va.gov.
Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Point of Contact listed below.
Point of Contact
Sam DeMuzio
Contracting Officer
Sam.demuzio@va.gov
36C24220Q0809 Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2
7/28/20, 3:03 PM